AGP Picks
View all

Sci-Tech North Carolina: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech North Carolina.

Press releases published on October 16, 2026

TruGolf Holdings Inc. (NASDAQ: TRUG) Acquisition Positions Company in Market for Regulated Tokenization, Digital Securities Infrastructure
Aprea Therapeutics to Host Pre-ESMO Virtual Panel on the State of WEE1 Inhibition in Precision Oncology
Once-Weekly TransCon® CNP (Navepegritide) Receives Positive CHMP Opinion for the Treatment of Achondroplasia in Children
Biomerica Reports First Quarter Fiscal 2027 Financial Results
When Is It Time to Replace Your Managed IT Provider? The Warning Signs, the Fear of Switching, and What a Smooth Transition Looks Like
ASUS ProArt P16 and P14, Powered by NVIDIA RTX Spark, Now Shipping in Canada
ASUS ProArt P16 & P14, Powered by NVIDIA RTX Spark, Now Available for Purchase in the United States
Aduro Clean Technologies Reports First Quarter Fiscal Year 2027 Results and Provides Business Update
NeOnc Reports Early Clinical Improvement in First Child Treated with NEO100 Under Compassionate Use in Abu Dhabi
twiist™ Automated Insulin Delivery System is Now Cleared for Adults with Type 2 Diabetes
NVIDIA RTX Spark PCs Available Today — A New Beginning for Windows PCs
MediaClaw Debuts Agentic AI Platform to Automate Public Relations
Quantum X Labs’ Cybersecurity Technology Achieves Significant Breakthrough with IBM Quantum Hardware
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
OXB Appoints Joachim Kreuzburg as Independent Non-Executive Director
Libtayo® (cemiplimab) Recommended for EU Approval by the CHMP for Updated Dosing Regimen Across All Approved Cancer Types
Tango Therapeutics to Present Updated Vopimetostat + RAS(ON) Combination Data at European Society For Medical Oncology (ESMO) Congress 2026
Fractyl Health's Revita Meets Six-Month Co-Primary Endpoint in Ongoing REMAIN-1 Pivotal Study, With Highly Statistically Significant Reduction in Weight Regain After GLP-1 Discontinuation
Adial Pharmaceuticals Appoints David Rubenstein, M.D., Ph.D., as Chief Scientist to Advance its Colon-Targeted AhR Agonist, AT177, for Ulcerative Colitis
Tiziana Doses Last Patient in Phase 2 Trial of Intranasal Foralumab for Mild Alzheimer’s Disease

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Sci-Tech North Carolina

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.